Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine (Q34217662)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine |
scientific article |
Statements
1 reference
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine (English)
1 reference
Lawrence M Gelbert
1 reference
Shufen Cai
1 reference
Xi Lin
1 reference
Concepcion Sanchez-Martinez
1 reference
Miriam Del Prado
1 reference
Maria Jose Lallena
1 reference
Raquel Torres
1 reference
Rose T Ajamie
1 reference
Graham N Wishart
1 reference
Robert Steven Flack
1 reference
Blake Lee Neubauer
1 reference
Jamie Young
1 reference
Edward M Chan
1 reference
Philip Iversen
1 reference
Damien Cronier
1 reference
Emiko Kreklau
1 reference
Alfonso de Dios
1 reference
13 June 2014
1 reference
1 reference
32
1 reference
825-837
1 reference
13 June 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference